Memorial Sloan Kettering Cancer Center 9th Annual MSK Symposium on Lymphoma 2025

Memorial Sloan Kettering Cancer Center 9th Annual MSK Symposium on Lymphoma 2025

 Include: 37 videos + 30 pdfs, size: 6.71 GB

 Target Audience: internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees

 Information:

This annual symposium provides a comprehensive overview of the latest advancements in the evolving field of lymphoma. Renowned national and international experts present cutting-edge discoveries in lymphoma biology, state-of-the-art diagnostic techniques, and innovative treatment strategies. The program highlights the clinical management of common lymphoma subtypes while also examining groundbreaking drug developments that are redefining patient care. Attendees will gain valuable insights into the latest findings in lymphoma biology and pathology, exploring how these breakthroughs are being translated into practical, impactful solutions for clinical practice.

The target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma. Participants have the choice of attending either in-person or virtually.

We look forward to welcoming colleagues and esteemed faculty from around the world to exchange insights and advance the future of lymphoma care.

1. Describe recent advances in lymphoma classification
2. Discuss first line treatment options in most frequent lymphoma entities
3. Describe new agents mode of actions, efficacy, side effects
4. Discuss options and recommendations for patients in the relapse refractory setting
5. Provide adequate information to help shared decision with patients regarding their treatment

 Topics:

• Advances in Biology.mp4
  Advances in Biology.pdf
  Advancing Therapeutic Options in the Relapse Setting.mp4
  Advancing Therapeutic Options in the Relapse Setting.pdf
  B-Cell Dynamics in the Germinal Center.mp4
  B-Cell Dynamics in the Germinal Center.pdf
  Biology of Hodgkin Lymphoma.mp4
  Biology of Hodgkin Lymphoma.pdf
  CAR T-Cell Therapy for B Cell Lymphoma- Approach to Management and Care in the Outpatient Setting.mp4
  CAR T-Cell Therapy for B Cell Lymphoma- Approach to Management and Care in the Outpatient Setting.pdf
  Cellular Therapies for Treating Mantle Cell Lymphoma.mp4
  Cellular Therapies for Treating Mantle Cell Lymphoma.pdf
  Current Dilemma in the First Line Therapy Setting.mp4
  Current Dilemma in the First Line Therapy Setting.pdf
  Epidemiology and Outcomes of Lymphoma.mp4
  Epidemiology and Outcomes of Lymphoma.pdf
  Germinal Center Biology.pdf
  Histologic Transformation of Follicular Lymphoma.mp4
  Histologic Transformation of Follicular Lymphoma.pdf
  Lessons and Challenges.mp4
  Lessons and Challenges.pdf
  Lymphoma Survivorship- Optimizing Quality of Life and Monitoring Long Term Side Effects of Treatment.mp4
  Lymphoma Survivorship- Optimizing Quality of Life and Monitoring Long Term Side Effects of Treatment.pdf
  Lymphoma2025_Brochure.pdf
  Management of Fertility in Patients with Hodgkin’s and Non-Hodgkin Lymphoma.mp4
  Management of Fertility in Patients with Hodgkin’s and Non-Hodgkin Lymphoma.pdf
  Management of Older Patients.mp4
  Management of Older Patients.pdf
  Mantle Cell Lymphoma in Ambulatory Setting- Focus on Supportive Care and Adverse Event Management.mp4
  Mantle Cell Lymphoma in Ambulatory Setting- Focus on Supportive Care and Adverse Event Management.pdf
  New Antibodies Engaging Immune Cells.mp4
  New Antibodies Engaging Immune Cells.pdf
  New Drugs on the Horizon for Follicular Lymphoma.mp4
  New Drugs on the Horizon for Follicular Lymphoma.pdf
  Notch and Marginal Zone Biology.mp4
  Notch and Marginal Zone Biology.pdf
  Optimizing First Line Therapy.mp4
  Optimizing First Line Therapy.pdf
  Optimizing Patient Selection in 2025.mp4
  Optimizing Patient Selection in 2025.pdf
  Options After First Line Treatment Failure.mp4
  Options After First Line Treatment Failure.pdf
  Panel Discussion- Advances in Therapeutic Strategies for Mantle Cell Lymphoma.mp4
  Panel Discussion- Aggressive B-Cell Lymphoma & Car T-Cell Therapies in Large B-Cell Lymphoma.mp4
  Panel Discussion- Aggressive B-Cell Lymphoma- Addressing Remaining Gaps on the Path to a Definitive Cure.mp4
  Panel Discussion- Current Challenges in the Management of Patients with Follicular Lymphoma.mp4
  Panel Discussion- Empowering APPs and Nurses.mp4
  Panel Discussion- Hodgkin Lymphoma.mp4
  Panel Discussion- Improving Outcomes of Patients with T-Cell Lymphoma.mp4
  Panel Discussion- The Dark Side of B-Cells.mp4
  Progress in Large B-Cell Lymphoma Management.mp4
  Progress in Large B-Cell Lymphoma Management.pdf
  Radiation Therapy and CAR T.mp4
  Recent Insights Into Mantle Cell Lymphoma Biology.mp4
  Recent Insights Into Mantle Cell Lymphoma Biology.pdf
  Research Spotlight- Updates of Active Hodgkin’s Lymphoma Protocols at Memorial Sloan Kettering.mp4
  Research Spotlight- Updates of Active Hodgkin’s Lymphoma Protocols at Memorial Sloan Kettering.pdf
  Single Cell Analysis of B-Cell Lymphoma.mp4
  Single Cell Analysis of B-Cell Lymphoma.pdf
  The Evolving Standard of Care in First Line.mp4
  The Evolving Standard of Care in First Line.pdf
  Treatment Initiation Versus Active Surveillance.mp4
  Treatment Initiation Versus Active Surveillance.pdf
  Update on Burkitt Lymphoma.mp4
  Update on Burkitt Lymphoma.pdf
  Update on Primary Mediastinal B-Cell Lymphoma.mp4
  Update on Primary Mediastinal B-Cell Lymphoma.pdf